Nifty  25683.30  -193.55  (-0.75%)

Sensex  83576.24  -604.72  (-0.72%)

USDINR  89.05  0.00  (0.00%)

Gujarat Kidney & Super Speciality Ltd
Registered Office:
Plot No.1 City Sarve No.1537/A,Jetalpur Rd Gokak Mill Compoun, Vadodara - 390020, Gujarat, India.
Initial public offering of 2,20,00,000 equity shares of face value of Rs. 2 each ("Equity Shares") of the company for cash at a price of Rs. 108-Rs. 114 per equity share (including a share premium of Rs. 106-Rs. 112 per equity share) ("Issue Price") aggregating to Rs. 237.6-Rs. 250.80 crores ("Issue"). The issue shall constituted 27.90% of the post-issue paid-up equity share capital of the company. The face value of equity shares is ?2 each. the issue price was 57 times the face value of the equity shares. Bids can be made for a minimum of 128 equity shares and in multiples of 128 equity shares thereafter.
Issue
Opens On Closes On
22-Dec-25 24-Dec-25
Money Payable On
Application Allotment
114.00 0.00
Minimum Application for shares in Nos : 128  Further Multiples of : 128
()(Cr.) Lead Managers to the Issue
Project Cost () 225.74 Nirbhay Capital Services Pvt ltd
Project Financed through Current Offer () 250.80  
Post Issue Equity Share Capital () 15.77  
Issue Price () 114.00  
Projects
Proposed acquisition of Parekhs Hospital at Ahmedabad
Part-payment of purchase consideration for the already acquired "Ashwini Medical Centre"
Funding of capital expenditure requirements of the company towards setting up of a new hospital in Vadodara
Buying robotics equipment for the hospital Gujarat Kidney & Super Speciality hospital in Vadodara Location
Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by the company
Acquisition of additional shareholding in the subsidiary namely "Harmony Medicare Private Limited" at Bharuch
Funding inorganic growth through unidentified acquisitions and General corporate Purposes
Promoted By
Pragnesh Yashwantsinh Bharpoda
Bhartiben Pragnesh Bharpoda
Yashwantsingh Motisingh Bharpo
Listing At
BSE
NSE
Registrar to the Issue